🇺🇸 FDA
Pipeline program

Ganoderma lucidum spore

NationalHealthyFood G20090069

Phase 2 small_molecule active

Quick answer

Ganoderma lucidum spore for Carcinoma, Non-Small-Cell Lung is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Carcinoma, Non-Small-Cell Lung
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials